Biotech Investors & VC Firms in New York
143 firms in this list, with a median first check of $500K. 31 of them lead rounds. Generated from verified public data and updated continuously.
Empire State Development – New York Ventures
New YorkPre-Seed–Series B$500K – $1.5M
9 people
Later Capital
New YorkPre-Seed–Seed
6 people
NGN Capital
New YorkSeries A–Late Stage
5 people
Metrodora Ventures
New York
1 person
Cerberus Capital Management
New YorkPre-Seed–Seed
3 people
ScienceVest
New YorkPre-Seed–Seed$125K
2 people
Syno Capital, LLC
New YorkSeries A
4 people
47 Ventures
New YorkPre-Seed–Growth$150K – $2M
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
4 people
Proton Enterprises
New YorkSeed–Series A
4 people
Dynamk Capital
New YorkSeed–Series B
4 people
Harvard Business School Alumni Angels of Greater New York
New YorkPre-Seed–Seed
3 people
Global Health Investment Fund
New York
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
eGenesis, Inc. Full-time
New York
3 people
Pura Vida Investments
New YorkLate Stage
Helaina
New York
2 people
Paliwoda Group
New YorkSeed–Series A
1 person
Z-Fellows
New YorkPre-Seed–Seed
1 person
LDJ Capital
New York
Arcus Ventures
New YorkSeed–Series A
4 people
Inning One Ventures
New York
3 people
LSI
New YorkPre-Seed–Seed
1 person
Golden Seeds
FlushingSeed–Series A$250K – $2M
63 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.









































